Pacific Edge shares rose 6.5 percent after the cancer diagnostics firm signed its first commercial deal to supply its suite of Cxbladder tests in Singapore.
The stock increased 2.5 cents to 41 cents after the Dunedin-based company said it reached a commercial agreement with a unit of Raffles Medical Group to use the bladder cancer tests in Singapore, the company said in a statement. Under the deal, the Raffles unit will coordinate specimen collection, shipping and reporting of Cxbladder tests for the medical firm's patients in the Asian city.
"We are delighted to work with the prestigious Raffles Medical Group in Singapore and whilst this is a relatively small commercial proposition for Pacific Edge, it offers a significant stepping stone into the Raffles Medical Group across South East Asia," Pacific Edge chief executive David Darling said. "The region remains an exciting proposition for Pacific Edge with approximately 9,500 urologists and an estimated 1.8 million potential tests."
Pacific Edge raised $21.3 million in a discounted rights issue last year, which it said left it flush enough to fund the operation until it starts breaking even in 2019.
The company's international ambitions have rested largely on breaking into the US market, although that's taken longer than expected, and started eyeing Singapore as a gateway to South East Asia in 2015.
Raffles operates in 13 cities across Singapore, China, Japan, Vietnam and Cambodia, and is in the only fully integrated private healthcare operation in Singapore.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- Russell McVeagh incident highlights complications of corporate sponsorship
- Sir Ralph explains why he didn’t listen but NZSA calls it a failure of governance
- Could Nikki Kaye lead National one day? A wee problem
- Poor facing double whammy when road congestion pricing gets off the ground
- The highest paid directors
Most listened to
- Ian Apperley goes cold turkey on social media, and claims he's now a better man
- Auckland Airport's CEO Adrian Littlewood explains the impact of price changes on revenue
- Competition lawyer Michael Wigley supports the Criminalisation of Cartels Amendment Bill
- Roadtrippers deal is a gamechanger, says Tourism Holdings CEO Grant Webster
- The sub-contracting model is killing the New Zealand construction industry, says E tū's Ron Angel
- NBR Radio: The best interviews – updated daily, with Grant Walker